Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients.

Saved in:
Bibliographic Details
Title: Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients.
Authors: Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Nesic M; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Reinert T; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Afterman D; C2i Genomics, Ltd., Haifa, Israel., Lauterman T; C2i Genomics, Ltd., Haifa, Israel., Kuzman M; C2i Genomics Inc., New York, NY 10014, USA., Gonzalez S; C2i Genomics Inc., New York, NY 10014, USA., Glavas D; C2i Genomics Inc., New York, NY 10014, USA., Smadback J; C2i Genomics Inc., New York, NY 10014, USA., Maloney D; C2i Genomics Inc., New York, NY 10014, USA., Levativ J; C2i Genomics Inc., New York, NY 10014, USA., Yahalom M; C2i Genomics Inc., New York, NY 10014, USA., Ptashkin R; C2i Genomics Inc., New York, NY 10014, USA., Tavassoly I; C2i Genomics Inc., New York, NY 10014, USA., Donenhirsh Z; C2i Genomics, Ltd., Haifa, Israel., White E; C2i Genomics Inc., New York, NY 10014, USA., Kandasamy R; C2i Genomics Inc., New York, NY 10014, USA., Alon U; C2i Genomics, Ltd., Haifa, Israel., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark., Jaensch C; Department of Surgery, Herning Regional Hospital, Denmark., Løve US; Department of Surgery, Viborg Regional Hospital, Denmark., Andersen PV; Department of Surgery, Odense University Hospital, Denmark., Thorlacius-Ussing O; Department of Surgical Gastroenterology, Aalborg University Hospital, Denmark., Iversen LH; Department of Clinical Medicine, Aarhus University, Denmark; Department of Surgery, Aarhus University Hospital, Denmark., Gotschalck KA; Department of Clinical Medicine, Aarhus University, Denmark; Department of Surgery, Randers Regional Hospital, Denmark., Zviran A; C2i Genomics Inc., New York, NY 10014, USA., Oklander B; C2i Genomics, Ltd., Haifa, Israel., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark. Electronic address: cla@clin.au.dk.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 211, pp. 114314. Date of Electronic Publication: 2024 Sep 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2024.114314